Investigation of Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. (SRPT) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between September 6, 2017 and August 19, 2019,
Sarepta Therapeutics, Inc. (SRPT) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between September 6, 2017 and August 19, 2019,
Resideo Technologies, Inc. (REZI) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between October 10, 2018 and October 22, 2019,
Henry Schein, Inc. (HSIC) Accused of Antitrust and Securities Violations Between March 2013 and February 2018, the executives of Henry Schein, Inc. (HSIC) engaged in a conspiracy with Benco
Mohawk Industries, Inc. (MHK) Accused of Channel-Stuffing According to the complaint for alleged violations of the Securities Exchange Act of 1934 between April 28, 2017 and July 25, 2019,
Welbilt, Inc. (WBT) Restates Consolidated Financial Statements due to Material Weakness Relating to Income Taxes According to the complaint, on November 5, 2018, the company filed a report with the
ForeScout Technologies, Inc. (FSCT) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between February 7, 2019 and October 9, 2019,
Trulieve Cannabis Corp. (TCNNF) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between September 25, 2018 and December 17, 2019,
Energy Transfer LP (ET) Accused of Bribery According to the complaint for alleged violations of the Securities Exchange Act of 1934 between February 25, 2017 and November 11, 2019, in
Canopy Growth Corp.’s (CGC) Accused of Misleading Shareholders According to the complaint for alleged violations of the Securities Exchange Act of 1934 between June 21, 2019 and November 13, 2019,
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.